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ABSTRACT
Invasion of melanoma cells from the primary tumor involves
interaction with adjacent tissues and extracellular matrix. The extent of
this interaction is not fully understood. In this study Raman
spectroscopy was applied to cryo-sections of established 3D models of
melanoma in human skin. Principal component analysis was used to
investigate differences between the tumor and normal tissue and
between the peri-tumor area and the normal skin. Two human
melanoma cells lines A375SM and C8161 were investigated and
compared in 3D melanoma models. Changes were found in protein
conformations and tryptophan conﬁgurations across the entire
melanoma samples, in tyrosine orientation and in more ﬂuid lipid
packing only in tumor dense areas, and in increased glycogen content
in the peri-tumor areas of melanoma. Raman spectroscopy revealed
changes around the perimeter of a melanoma tumor as well as
detecting differences between the tumor and the normal tissue.
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Introduction
The incidence of melanoma is increasing in all countries (1). In the UK, incidence rates
increased by 250% between the years 1975–1977 and 2006–2008 making it the ﬁfth most
common cancer in the UK (2). Until recently, therapeutic options for melanoma (outside of
early excision for thin melanomas which have a good prognosis) have had little to offer in
terms of survival but recent targeted therapies with BRAF inhibitor drugs for tumors with
BRAF mutations have improved survival (3).
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Despite this there is much still to learn about the mechanism of melanoma tumor pro-
gression. Transformation into malignancy involves multiple (likely concurrent) steps which
may consist of both mutations and environmental factors (4). Of particular interest is the
suggestion that changes in the microenvironment may promote progression and invasion
following transformation (5).
The MacNeil Group have a well-established human melanoma model which has been
used to look at aspects of melanoma cell interaction with adjacent tissues (6–8). These mod-
els offer opportunities to look at some of the tumor cell-normal cell interactions which can-
not be easily investigated in man or in animals. Prior studies suggest interactions between
melanoma cells and the adjacent tissues may inﬂuence metastatic spread (6,7).
In this study we employ Raman spectroscopy to learn more of these interactions. It has
increasingly been used in the identiﬁcation of a range of solid tumors—e.g., breast (9,10),
lung (11), testicular (12), and bladder (13). As an investigational tool it has much to offer
and this is becoming evident in increasing studies in which Raman has been shown to dis-
criminate between, for example, breast cancer cells of different stages of progression (10), to
discriminate between drug resistant and sensitive testicular cell lines (12) and to be able to
distinguish between tumor and normal tissue in tissue biopsies (9).
Our aim was to investigate the use of Raman micro-spectroscopy to obtain information
that may help in distinguishing melanoma tissue from normal tissue and to analyze the area
around a tumor that may have been inﬂuenced by the tumor cells. It is hypothesized that it
may be possible to detect a peri-tumor area using Raman spectroscopy which may identify
new targets for the arresting of melanoma metastases.
Materials and methods
Access to human skin
Skin samples were obtained with written informed consent from patients undergoing elec-
tive surgery for breast reductions and abdominoplasties from the Shefﬁeld Teaching Hospi-
tals. Tissue was collected with Ethical Approval from the National Research Ethics Service
(NRES) Yorkshire & The Humber–Shefﬁeld (REC 15/YH/0177). Skin was used for the prep-
aration of de-epidermized dermis (DED) and the isolation of keratinocytes and ﬁbroblasts.
Skin samples were processed within 24 h of receipt.
Cell culture
Keratinocytes were cultured in Keratinocyte Culture Medium (KCM). This medium consists
of Dulbecco’s modiﬁed eagle’s medium (DMEM) (Biosera, UK) and Ham’s F12 medium
(Labtech, UK) in a 3:1 ratio supplemented with 10% FCS, 10 ng/ml EGF, 0.4 ug/ml hydro-
cortisone, 1.8 £ 10¡4 M adenine, 5 ug/ml transferrin, 5 ug/ml insulin, 2 £ 10¡3 M gluta-
mine, 2(10¡7) mol/l triiodotyronine, 0.625 ug/ml amphotericin B, 100 IU/ml penicillin, and
100 ug/ml streptomycin. Fibroblast culture was carried out in Fibroblast Culture Medium
(FCM). This consists of DMEM supplemented with 10% FCS, 2 £ 10¡3 M glutamine, 100
IU/ml penicillin, 100 ug/ml streptomycin, and 0.625 ug/ml amphotericin B. Their isolation
followed a previously described protocol (6).
The A375SM cell line was obtained from Professor I. J. Fidler via M. J. Humphries (Uni-
versity of Manchester) (6). This cell line is from lymph node metastasis of a 54-year-old
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female. These cells were maintained in Eagle’s modiﬁed essential medium (EMEM) (Biosera,
UK) supplemented with 10% FCS, 2uM l-glutamine, 100 IU/ml penicillin and 100 ug/ml
streptomycin, 1.2 ug/ml fungizone, 1.5% (100x stock) vitamin concentrate, 1mM sodium
pyruvate, 10% non-essential amino acids, and 0.187% sodium bicarbonate at 37C.
The C8161 cell line was a gift from Professor F. Meyskens via M. Edwards (University of
Glasgow) (6). This cell line is from an abdominal wall metastasis from a woman with recur-
rent malignant melanoma. The cells were maintained in supplemented EMEM as for the
A375SM cell line. Reagents were all obtained from Sigma Aldrich unless otherwise stated.
Tissue-engineered model construction
Tissue-engineered skin (TE skin) and melanoma models were made according to a previ-
ously described protocol (7). All models—tissue-engineered skin and models of tissue-engi-
neered skin containing melanoma cells—were incubated at an air-liquid interface (ALI) for
14 days with a media change every 2–3 days. They were then ﬁxed in 3.7% formaldehyde for
a minimum of 24 h before further processing. Samples were then placed in 30% (w/v)
sucrose in PBS for a minimum of 2 h then sandwiched between layers of optimum cutting
temperature (OCT) compound (Leica biosystems) inside cryomoulds, frozen in liquid nitro-
gen and stored at ¡80C until required. A Leica cryostat (Leica CM1860 UV) was used to
cut adjacent sections to a thickness of 6 mm onto glass slides for H&E staining, and to 20–
25 mm onto either glass, quartz or CaF2 for Raman analysis.
Raman spectrometers
Instrument 1: DXR Raman Microscope for all single-point collections (Thermo Scientiﬁc,
USA). A 532 nm diode laser and 633 nm He Ne laser were used with grating of 900
and 600 l/mm, respectively, producing a system resolution of »6 cm¡1. All measure-
ments were collected using a 50x lwd objective NA 0.50 (Olympus LMPlanFL N).
Laser power was 10 mW. Collection times varied from a single 30s exposure to 5£60s
exposures depending on sample thickness, substrate, and laser.
Instrument 2: InVia Raman Microscope Renishaw, UK for StreamLine mapping of
A375SM model sections. The microscope was conﬁgured with a 532 nm laser and a
600 l/mm grating resulting in a spectral resolution of »5 cm¡1. Streamline imaging
uses a laser line geometry and collects multiple spectra at a time. Employing a 50x NA
0.75 objective, the laser line was approximately 40 mm in length. Laser power at the
sample was»37 mW (spread across the laser line) and the exposure time was 13 s/line.
Processing and analysis of Raman data
For normal TE skin samples, spectra were collected from random points on each of the tis-
sue layers: stratum corneum (SC), epidermis and dermis. These layers were easy to identify
on white light images and then conﬁrmed from the adjacent H&E stained sections. For mela-
noma samples, location of every sample point was recorded on the white light image of the
sample area. These points were then compared to adjacent H&E stained sections to deter-
mine the corresponding tissue type/layer.
Substrate spectra were subtracted from tissue spectra for all single-point collections using
OMNIC (Thermo Scientiﬁc, USA). Peak positions were measured on TQ Analyst (Thermo
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Scientiﬁc, USA) as the position of maximum height of a peak within a deﬁned range.
Unscrambler X (CAMO, Norway) was used for PCA. Data was baseline corrected and unit
vector normalized (UVN). Every PCA was setup with a minimum of 12 orthogonal variables
to explain >98% of the variance.
Height measurements of the high wavenumber region of tissue sections were performed
on TQAnalyst. The height of peaks at the ﬁxed locations of 2930 (yCH3 of protein), 2880
(yCH2(asym) of lipids), and 2840 (yCH2(sym)) of lipids cm
¡1 were measured from the baseline.
Values for I2930/I2840 indicate the lipid content relative to protein content and I2840/I2880
tracks the lateral packing order of lipids. OriginPro (OriginLab, USA) was used to measure
the intensity of the tryptophan doublet. This was done by peak ﬁtting to the tryptophan dou-
blet with ﬁxed centers at 1360 and 1340 cm¡1 to the ﬁrst derivative spectra.
A375SM map data were analyzed using unsupervised hierarchical clustering (HCA)
implemented in CytoSpec (www.cytopec.com). Spectra were clustered together based on
spectral similarities and were assigned false colors, generating a false color map. The distance
was calculated by D-value method, and the clustering by Ward’s algorithm. Six clusters were
chosen to represent the map. An average spectrum for each cluster was calculated for chemi-
cal analysis.
Results
Tissue-engineered melanoma model containing A375SM cells
Figure 1 illustrates typical appearances of these 3D models which were divided into three
common morphological types (1) areas with clusters of assumed A375SM cells encapsulated
Figure 1. Haematoxylin and Eosin staining of A375M melanoma models showing three morphological cat-
egories. Histological images of (A) a section of normal HSE, (B-D) A375M cells in cluster within the epider-
mis (shown by arrows), (E) the spread of A375 cells over the surface of the composite and (F) no apparent
A375M cells.
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within the epidermis, (2) areas with A375SM cells spread over the tissue-engineered surface,
and (3) areas which looked like normal tissue-engineered skin despite the inclusion of mela-
noma cells.
Regional variations in category 1 areas using principle component analysis (PCA)
Five areas of around 200–300 mm2 from three A375SM samples were selected to study com-
positional differences in clustering regions. Each area included a tumor cluster with deﬁned
borders distinct from the surrounding tissue. Every spectra from these areas was location-
labelled and then color coded for: (i) tumor cluster (blue), (ii) epithelial tissue surrounding
the cluster (green), and (iii) dermis (red). An example PCA over a category 1 region is shown
in Fig. 2. For each of the ﬁve areas, the PCA scores plots contained a PC that separates der-
mis from the superﬁcial layers and a PC that separates tumor clusters from surrounding
Figure 2. PCA results of a A375SM category (1) area. (A, B) White light and H&E images of the PCA area.
(C) Scores plot for the PCA setup over the region 450–1800 cm¡1. Data points are color-coded based on
H&E features. (D) PC loadings corresponding to (C). Loadings that separate tumor from surrounding tissue
highlights areas associated with various AAs, lipid phase, and amides.
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tissues. PCs that separate dermis from superﬁcial layers include features related to collagen
(1140–1300 cm¡1 and 920, 855 cm¡1), nucleic acid (NA) residues (1300–1400 cm¡1) and
lipids (1060–1140 cm¡1) (Figure 2c). These bands bear a close resemblance to features that
allow one to separate the layers of normal skin. Loadings for PCs that separate tumor clus-
ters from the surrounding tissue describe differences in Amide bands, lipid phase, as well as
some signiﬁcant contributions from glycogen and amino acid (AA) residues.
Differences in protein structure within A375SM clusters
The position of the Amide I peak in layers of normal TE skin show predominantly a-helical
proteins in the epidermis and b-sheet proteins in the dermal layer (Figure 3a). For A375SM
models, the dermal spectra and epithelial layers surrounding and further away from the
tumor clusters exhibit a similar band shape. A higher percentage of unordered and b-sheet
conformations rather than a-helix were found in tumor clusters (Figure 3b). This was seen
consistently in all clearly deﬁned tumor clusters within the epidermis, indicating conforma-
tional alterations in the proteins of A375SM cell clusters.
Higher percentage of gauche lipids in A375SM models
In normal TE skin there was a near equal contribution of both trans and gauche lipids
observed in the epidermis. In contrast to this, A375SM clusters and epithelial tissue some
Figure 3. Features of A375SM (middle) and C8161 (right) models compared to normal TE skin (left). (A–C)
1st derivative spectra of Amide I band. Percent contribution of a-helix, unordered, and b-sheet proteins
(39) in melanoma-dense clusters and surrounding epithelial tissue are different. (D–F) Raman spectra of
spectral range 450–700 cm¡1 showing an increase in the glycogen peak at 481 cm¡1 relative to the y(C-
S) peaks at 640 and 620 cm¡1 tumor surrounding tissue.
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distance away from these clusters (category 3 areas) showed a higher contribution of gauche
lipids. The biggest difference was observed at the surface (category 2 areas) where the trans-
to-gauche ratio was much lower compared to that seen in normal TE skin surface (Table 1).
Increased glycogen surrounding A375SM clusters
There was a major difference between the epidermis surrounding the A375SM clusters and
normal TE skin at 481 cm¡1 (Figures 3d,e). This peak represents the skeletal deformation of
glycogen (14). This was found in areas around the melanoma clusters but not in the mor-
phologically normal epidermis distant from the clusters or epidermal areas where the
A375SM cells were spread over the surface. The latter in particular suggests localized glyco-
gen accumulation in epidermal tissues in the vicinity of the tumor clusters but that the whole
epidermis is not activated. This glycogen storage response appears to extend to at least
100 mm from the tumor clusters.
Differences in AA residues in A375SM models
Peaks attributed to Tryptophan (Trp), Phenylalanine (Phe), and Tyrosine (Tyr) showed
apparent sensitivity toward separating tumor areas from surrounding tissue (Figure 2c). The
differences are summarized in Table 1. The ratio I1360/I1340 from the Fermi doublet of Trp is
considered a marker for its conﬁguration within proteins (15). It details whether the Trp
chains are exposed (I1340 >> I1360) or folded within the protein (I1340 > I1360). In normal
skin, the ratio is lower in SC compared to epidermis. This reﬂects hydrophobicity in the SC
(16). Trp chains are folded within the protein and inaccessible to water molecules. Tumor
clusters exhibit this same conﬁguration even when the cluster is within the epidermis.
Another Fermi doublet is seen at 850 and 830 cm¡1 that arises from vibrations of the pheno-
lic ring of Tyr (17,18). Tyr chains are exposed and free to form intra-molecular bonds when
the ratio I850/I830 is approximately 10:8. Changes to this ratio reﬂect changes to the ioniza-
tion state of this AA. An increase seen in the 830 cm¡1 peak within most tumor areas likely
Table 1. Signiﬁcant band positions and ratios relating to the form of proteins and lipids in melanoma and
normal skin models.
Tissue (Carea) 2930 cm¡1 position I1340/I1360 I2930/I2840 I2840/I2880
Normal skin
SC 2930.60 (2928.92–2931.53) 1.73 (1.11–2.16) 2.94 (2.52–3.24) 0.58 (0.55–0.64)
Epidermis 2930.47 (2925.05–2931.42) 3.66 (1.66–5.49) 2.73 (2.38–3.12) 0.58 (0.56–0.58)
Dermis 2939.11 (2927.76–2940.67) – 6.01 (5.61–6.74) –
A375SM models
Epidermis (surrounding
clusters)
2932.31 (2930.79–2933.44) 1.82 (1.63–1.92) 3.24 (2.41–5.91) 0.53 (0.46–0.59)
A375SM clusters 2933.06 (2931.1–2934.76) 1.99 (1.52–2.08) 2.77 (1.67–3.89) 0.61 (0.49–0.77)
Surface A375SM layer 2931.39 (2930.75–2933.4) 1.88 (1.57–2.18) 1.85 (1.53–2.35) 0.79 (0.67–0.87)
Dermis 2939.28 (2938.72–2940.28) – 7.66 (4.90–9.58) –
C8161 models
Epidermis I (surrounding
clusters)
2932.42 (2931.7–2933.2) 1.95(1.51–2.37) 3.04 (2.56–3.35) 0.57 (0.52–0.64)
Epidermis II (surrounding
swirls)
2932.11 (2931.1–2931.4) 1.88 (1.52–2.24) 3.25 (3.07–3.48) 0.55 (0.51–0.57)
C8161 clusters 2932.16 (2932.12–2932.40) 1.66 (1.53–1.80) 2.48 (2.15–2.80) 0.65 (0.60–0.72)
Surface C8161 layer 2932.45 (2931.9–2932.9) 2.38 (1.74–3.36) 2.74 (2.19–3.42) 0.64 (0.54–0.71)
Dermis 2938.99 (2936.6–2940.4) – 6.76 (4.26–8.59) –
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describes buried Tyr chains. Changes in these two AAs together suggest a more hydrophobic
environment within the A375SM tumor clusters.
Mapping of A375SM tissue-engineered models category 2 areas
Figure 4 shows a Raman map from an A375SM category 2 area. The map is based on HCA
of Raman spectra obtained in the 400–3200 cm¡1 region setup for division into 6 clusters.
Five of these clusters described some area of the mapped tissue whereas the sixth cluster
Figure 4. (A) H&E stained mapping area of an A375SM sample. (B) HCA pseudocolor map of sample area
on an unstained adjacent section to (A). (C) Cluster averaged spectra of the map area highlighting peaks
separating the tumor dense and surrounding tissue.
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nearly exclusively traced all quartz spectra. Several spectral differences are observed in the
cluster averaged spectra pointing to biochemical differences in the superﬁcial layer contain-
ing melanoma cells (cyan, pink) and the viable epidermis (green, pink). 1604 cm¡1 of Phe
and Tyr and 1002 cm¡1 of Phe appear to be higher in uppermost superﬁcial layer (cyan)
compared to 1554 cm¡1 of Trp but vice versa in the rest of the superﬁcial layer (pink). There
is a difference in the distribution of nucleic acids, represented in the 1300–1400 cm¡1 region,
throughout the epithelial layer (cyan, pink, green), resulting in a subdivision into 3 different
clusters. The dermal spectra (blue, gray) are very similar to those obtained from
tissue-engineered normal skin models and show high concentrations of collagen (855, 920,
1247, 1271, 2980 cm¡1 and Amide I shift towards b-sheet).
Tissue-engineered melanoma models containing C8161 melanoma cells
The morphological features of these tumor models containing C8161 cells were more hetero-
geneous compared to models with A375SM cells. Sample features were accordingly divided
into four categories, as illustrated in Fig. 5. These were: (1) areas with high densities of
C8161 cells spread across the surface, (2) areas where large numbers of C8161 cells had
invaded the dermis in close proximity to the basement membrane, (3) areas with clusters of
assumed C8161 cells encapsulated within the epidermis, and (4) areas with no apparent
C8161 cells. Category (1) areas with high densities of C8161 cells spread across the surface
were nearly always accompanied by large swirls where the epidermis was apparently degrad-
ing as illustrated in Figures 5b,c.
Figure 5. H&E staining of C8161 melanoma models showing four morphological categories. (A) section of
normal HSE, (B–D) areas with C8161-dense surface-layers and areas with clusters of C8161 cells within the
epidermis, (E) areas with C8161 cells invading into dermis, and (F) morphologically normal areas within
C8161 models.
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Spectral features of category 1 and 3 areas for C8161 cells
PCA loadings (Suppl. Fig. 1) indicated AA bands for Tyr and Phe are different in melanoma-
dense areas versus surrounding tissue. In particular, a peak at 1583 cm¡1 that represents
d(C D C) vibrations of Phe (10) is greatly increased in the surface C8161 layer compared to
the rest of the sample areas. Another notable feature that repeated in most of the PCAs was
seen at 781 cm¡1. This peak consistently separated the surface layer (where it was the high-
est) and the epidermal swirls (where it was the lowest) from other surrounding tissues. The
peak represents Uracil based ring breathing modes of DNA and RNA (10) which likely
reﬂect high cell densities in the surface layer. Several other spectral changes identiﬁed in
C8161 tumor areas that were similar to those found in the A375SM models are summarized
in Figure 3c,f. In Amide I, a greater number of unordered and b-sheet proteins are seen in
C8161 clusters compared to normal TE skin, even in epithelial areas some distance from the
melanoma-dense regions. Again, the lipid phase of these melanoma-dense areas appeared
more ﬂuid and the epithelial tissue surrounding the C8161 melanoma clusters showed
increased glycogen storage. One feature that was unique to the C8161 models was a change
in the ratio of the sulphide peaks at 640 and 620 cm¡1 (Suppl. Fig. 2). Approximately 75% of
spectra from category (1) areas show an increase in the intensity of the 620 cm¡1 peak—this
was not seen in any of the other normal TE skin or melanoma models.
A comparison of spectral features found in A375SM and C8161 melanoma models
The two melanoma cell lines used in this study represent two different stages of melanoma
that may be found in the clinic. A375SM are comparable to stage II. In contrast, C8161 cells
are highly invasive and comparable to stage III or IV. Spectral differences between these two
tumor cell lines in these melanoma models were compared to see how they interacted with
the surrounding tissue.
Both cancer models showed increased glycogen storage in epithelial tissues surrounding
tumor clusters compared to normal skin (A375SM > C8161). Other signiﬁcant band ratios
between A375SM, C8161, and normal tissue-engineered skin models are highlighted in
Table 1. A number of these are protein-speciﬁc. (1) There are minor differences in the 2930
cm¡1 protein band in cancerous tissues. The shifts here are small but consistent in all cancer
samples and might suggest some disorganisation in protein architecture of whole tissue-
engineered melanoma models. (2) Within tumor clusters of both cell types, and surface-
spread tumor layers, the Amide I position strongly suggests a higher percentage of unor-
dered and b-sheet conformation proteins instead of a-helix: unordered < b-sheet in clusters
but b-sheet < unordered in surface-spread layers. As it is observed in both cell line models,
it is possible that the differences in these ratios are: (i) an indication of the proliferative state
of the melanoma cells or (ii) some requirement of a clustering mechanism that ensures cells
bind to each other rather than migrate without boundaries. (3) The ratio I1340/I1360 repre-
sents the ratio of surface exposed versus buried Trp moieties within epidermal proteins. In
cancer models, there is an increase in the number of buried Trp chains. (4) Apart from struc-
tural differences, protein-to-lipid ratios within the models also show some variation. While
the overall lipid content is the same, the packing order of lipids is not. Compared to normal
skin, cancer models show a higher percentage of gauche lipids in areas of every tumor-
invaded category.
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Discussion
There is considerable evidence that there are important interactions between the tumor and
the microenvironment that includes ﬁbroblasts, endothelial cells, immune cells, soluble mol-
ecules, and the extracellular matrix (ECM) (19–21). Although these 3D in vitro melanoma
models cannot recapitulate all of these interactions (as they lack an immune system and a
vasculature) they can reﬂect the impact of an intact basement membrane and the presence
of normal keratinocytes and ﬁbroblasts on melanoma tumor invasion (6,7). The two mela-
noma cell lines used in this study demonstrate dramatically different invasive behavior.
C8161 cells are aggressively invasive irrespective of the presence or absence of skin cells
while A375SM cells have shown reduced invasion in the presence of normal skin cells (6).
The aim of this study was to use these established 3D models of melanoma as in vitro
experimental models to assess the potential usefulness of Raman spectroscopy to distinguish
tumor from normal tissue and to investigate the tissue area around the tumor to see to what
extent this is normal or abnormal.
As expected these show major morphological differences compared to normal tissue-
engineered skin and a small range of morphological variations within themselves. To handle
these variations, only morphological differences that were consistent in the sample groups
were selected and assigned a category. PCA was performed over these areas and features
that held true for all areas of a respective category were focused upon. For the A375SM mod-
els trends in several spectral bands were observed repeatedly in the spectra separating mela-
noma-dense areas from surrounding tissues. Furthermore, there was evidence of glycogen
accumulation in the tissues surrounding tumor clusters in the epidermis.
The major changes that were detected between the tumor and the normal tissues were
changes in protein conﬁguration and amino acid orientation. With respect to protein conﬁg-
uration Amide I suggests the ratio of a-helix, unordered, and b-sheet proteins are different
in the epidermis of cancer models compared to normal skin models. Based on this band
alone, the conformations of proteins were strictly maintained in normal TE skin (there were
only very minor changes to this ratio throughout the epithelial layers in all samples), whereas
it appears that melanoma cells comprehensively altered these protein structures. The ratio
was even different between melanoma clusters and surface-spread melanoma layers suggest-
ing the protein conformation states to be dynamic.
With respect to AAs, three were of interest: Phenylalanine (essential), Tryptophan (essen-
tial), and Tyrosine (conditionally non-essential). These AAs belong in a family of proteins
critical role in regulating homeostasis via their catabolic products and through their function
in key sites for enzyme activation. Quantiﬁcation is difﬁcult due to mode mixing. We report
instead that the orientation of Trp and Tyr are different in the cancer models. This likely
suggests some changes to the activity of Trp and Tyr mediated products. The exact changes
cannot be elucidated based solely on Raman data from these samples but examples of how
even minor changes in Trp and Tyr can affect tissues are discussed below.
Looking into this in more detail for Trytophan: I1340/I1360 ratios indicate a higher percent-
age of proteins with buried Trp chains in cancer samples compared to the normal skin
model. Trp is mostly used up through the kynurenine pathway and its catabolic products
are immunoregulatory. Changes to its rate of breakdown are implicated in several diseases
including HIV and neurodegenerative disorders (22–24) because the catabolic products are
thought to facilitate immune tolerance (25). The rate-limiting step of the breakdown is via
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the enzymes tryptophan-dioxygenase (TDO) or indolamine-dioxygenase (IDO). TDO and
IDO activity is dependent on the hydrophobic pocket formed when the Trp chain is buried
within the protein (26). Reducing the hydrophobic nature (changing the shape of the activa-
tion pocket) affects substrate binding (27). In all areas of the cancer samples, I1340/I1360 ratios
suggest hydrophobic pockets exist in a greater number of proteins compared to normal skin.
More active TDOs could mean increased Trp catabolism in cancer samples. Another theory
is that the buried state of Trp chains may be markers for the proliferative state. This theory
is mostly based on ﬂuorescence spectroscopy studies. Trp ﬂuorescence increases as Trp moi-
eties are folded into proteins versus when exposed. Using this method, the amount of buried
chains are found to increase in skin with UV exposure and after tape stripping of the SC
(28) and in the non-involved skin parts of psoriasis patients (29). These groups report
increases in ﬂuorescence that correlate with proliferative activity. This suggests that prolifer-
ation in all areas of A375SM models is greater than in normal skin epidermis. In C8161
models, while the epidermis and C8161 cell clusters show very high rates of proliferation,
the rate appears to be lower in surface-spread C8161 cells. 1360 and 1340 cm¡1 peaks repre-
sent the aromatic ring breathing vibrations of Trp. However, the ﬁrst step of Trp degradation
directly involves the indole ring. Vibrations associated with this ring at 1550, 1490, and 1430
cm¡1 (30) are likely to be more informative because this pathway regulates systemic Trp lev-
els. The problem is that, here, these peaks are either very weak (1550 cm¡1) or are overpow-
ered by other stronger bands (1490 and 1430 cm¡1). Trp-speciﬁc trends in tissues may be
better studied with UV Resonance Raman as Trp peaks are enhanced by several orders of
magnitude using this method (31,32).
With respect to Tyrosine, PCA suggests a greater number of buried Tyr chains in the clus-
ters and surface-spread melanoma cells. Tyrosine is found in key tyrosine kinase (PTK)
enzymes involved in signal transduction. Protein kinase enzymes are activated via a phos-
phorylation reaction on AA residues serine, threonine, and tyrosine and regulate a number
of vital metabolic and secretory processes. Kinases share a common fold but differ in terms
of the charge and hydrophobicity of AA residues. The shape and form of the hydrophobic
pockets arising from these differences inﬂuence substrate speciﬁcity (33). In the case of PTK,
a single Tyr chain is phosphorylated for activation. After this, interaction of the Tyr residue
with a neighboring arginine residue activates PTK by opening up and stabilizing a hydro-
phobic, substrate-binding site (34). PTK activation in normal cells is strictly regulated
according to need. Critically, any disruptions to the balance may lead to cell transformations
and unregulated cell growth (35). Drugs such as Imatinib inhibit this enzyme by binding to
the active site, preventing other substrates from binding it. This is an effective treatment in
some cancers such as Chronic Myelogenous Leukemia (CML) where PTKs are permanently
activated (34). Changes to the I850/I830 ratio compared to normal skin are important because
they imply some changes to the location/orientation of Tyr chains within proteins. Markers
of Tyr hydrophobicity have been shown to play a critical role in PTK function: replacing a
buried Tyr chain with polar residues that reduce hydrophobicity also decreases substrate
binding (36). Interestingly, in this study changes to Trp conﬁguration were seen in the entire
cancer samples whereas changes to Tyr conﬁgurations were seen nearly exclusively only in
melanoma-dense clusters and layers.
Another interesting ﬁnding however was the area around the tumor which could be
conﬁdently identiﬁed as distinct from both high density tumor and normal tissue. In
this area the changes we observed were localized glycogen accumulation in the primary
254 C. YORUCU ET AL.
D
ow
nl
oa
de
d 
by
 [R
oy
al 
Ha
lla
ms
hir
e H
os
pit
al]
 at
 08
:39
 22
 Fe
br
ua
ry
 20
16
 
surrounds of tumor clusters located within the epidermis of these melanoma models.
The effect was localized to areas only in the primary vicinity of clusters, not the entire
epithelial layer. Glycogen storage is known to be a stress response. Exposure to UV
radiation (37) or conditions such as psoriasis (38) cause increased glycogen storage
across the entire skin areas affected by these conditions. The activation cannot be due
to an immune response as these models do not contain any immune cells. This stress
response more likely arose from changes to the microenvironment with the keratino-
cytes responding directly to the melanoma clusters. In A375SM models, it was previ-
ously found that melanoma clusters result in degradation of the epidermal layer (7).
The degradative action may activate mechanisms associated with wound healing which
are also known to increase glycogen storage in keratinocytes (39).
In summary, we present data that shows RS is a valuable tool for interrogating tumors in
situ—as demonstrated here with tissue-engineered models. We show in these models that
melanoma cells induce changes in the surrounding tissue that are also common to other
diseases.
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